Please assess the completion status of the following clinical trial:

Trial Title: Phenytoin and Multidose Activated Charcoal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Phenytoin level \> 30 mg/L~Exclusion Criteria:~* Age \< 18~* Known allergy to Activated Charcoal~* Pregnant~* Inability to take PO drugs~* Non English speaking~* Inability to give consent~* Any prisoners

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Multiple Doses of Activated Charcoal (Type: EXPERIMENTAL): Patients will receive 50 grams of activated charcoal by mouth every 4 hours until phenytoin levels drop below 25 ug/cc
- Control (Type: NO_INTERVENTION): Will not receive activated charcoal. Serum levels will be followed.

Based on this trial design, predict the completion outcome and termination type (if applicable).